Skip to main content

Solutions for Novel Coronavirus (SARS‑CoV‑2) Research

The end of 2019 saw the emergence of a new coronavirus, called SARS‑CoV‑2, that is spreading quickly throughout the world and causing Coronavirus disease 2019 (COVID‑19). COVID‑19 is a respiratory illness that produces mild symptoms in most individuals; however, for certain groups of people, responses can be more severe and may lead to death due to gradual respiratory failure. The scope of this outbreak has scientists diligently trying to determine the pathogenic mechanisms of SARS-CoV-2 infection so to develop effective treatments. As a leader in the life sciences research sector, Bio-Techne has resources to support coronavirus research. Download our new brochure to learn more about our large portfolio of tools for SARS‑CoV‑2 research including:

  • Novel tools for detecting SARS‑CoV‑2 in cells and tissue.
  • Single and multiplex immunoassay solutions for monitoring the cytokine storm.
  • High quality reagents for the isolation, optimized kits for the differentiation and expansion, and flow cytometry-validated antibodies for the identification of immune cells.
  • Innovative technologies and instrumentation vital for the development of Anti SARS‑CoV‑2 therapies.